Nuclear Cardiology Markets

Table of Contents for Nuclear Cardiology Markets

Table of Contents:

1. Overview 5
1.1 Objectives 5
1.2 Scope 6
1.3 Methodology 6
1.4 Executive Summary 6
2. Medical Imaging Market Analysis 9
2.1 Medical Imaging Industry Market Size 9
2.2 Medical Imaging Infrastructure 10
2.2.1 Total Healthcare Expenditures and Demographics 10
2.2.2 Number of Hospitals 11
2.2.3 Number of Radiologists 12
2.2.4 Radiology Services 13
2.2.5 Medical Imaging Companies 15
2.2.6 Market Drivers 15
2.2.6.1 Product Enhancements 16
2.2.6.2 Contrast Agents Development 16
2.2.6.3 Innovation 16
2.2.7 Market Restraints 17
2.2.8 Market Segments for Medical Imaging 17
2.2.8.1 Discovery 17
2.2.8.2 Clinical Applications 18
2.2.8.3 Clinical Trials 18
2.2.8.4 Outpatient Facilities 18
2.2.8.5 Technology Advances in Diagnostic Imaging Modalities 18
2.2.8.6 Safety and Ergonomics Concerns 18
2.2.8.7 Volumetric Imaging 19
2.2.8.8 Digital Radiography (DR) 19
2.2.8.9 Contrast Media 20
3. Nuclear Medicine and Nuclear Cardiology Market 21
3.1 Medical Imaging Industry Forecasts 21
3.2 Hardware Companies (Nuclear Medicine Instrumentation) 22
3.3 Software Companies (Image Processing and PACS) 22
3.4 Radiopharmaceuticals and Pharmaceuticals Companies 23
3.5 Ancillary Products Companies 23
3.6 Service and Support Companies 23
3.7 Nuclear Cardiology Market 23
3.8 Hardware (PET, SPECT and Hybrids) 25
3.8.1 Scanner Investment: Not Just a Cardiology Market 25
3.8.1.1 Impact of Alzheimer's Reimbursement 26
3.8.2 Sales Trends for PET Scanners 26
3.8.3 Market Consolidation in the U.S. 26
3.8.4 Learning Curve Impact for PET 27
3.8.5 Hardware Market Trends 27
3.9 Software (PACS and RIS) 28
3.10 Radiopharmaceuticals 29
3.10.1 Diagnostic Radiopharmaceuticals 29
3.10.2 Therapeutic Radiopharmaceuticals 29
4. Products Analysis 30
4.1 Nuclear Medicine Instrumentation 30
4.1.1 PET Scan 30
4.1.2 SPECT Scan 31
4.1.2.1 Heart Imaging 33
4.1.3 PET Versus SPECT 34
4.1.4 Hybrid Technology 34
4.2 Image Processing: PACS 38
4.2.1 Making PACS Work with Nuclear Medicine 38
4.2.1.1 Failure to Communicate 38
4.2.1.2 3-D and Quantitative Analysis 39
4.2.1.3 Yale's PACS Makeover 39
4.2.1.4 Color Issues 40
4.2.1.5 Small Market Opportunities 40
4.2.1.6 Looking Ahead 40
4.3 Radiopharmaceuticals and Pharmaceuticals 41
4.3.1 Introduction 41
4.3.2 Background 41
4.3.3 Areas of Current Interest 42
5. Regulations, Reimbursements and Other Issues 44
5.1 Food and Drug Administration (FDA) 44
5.1.1 FDA Guidance 44
5.1.2 FDA Nuclear Medicine Coalition 44
5.2 U.S. Nuclear Regulatory Commission (NRC) 44
5.2.1 What NRC Regulates 44
5.2.2 How NRC Regulates 45
5.2.3 Related Information 45
5.3 Memorandum of Understanding between NRC and FDA 45
5.3.1 Authorities and Regulatory Programs 45
5.4 Current NRC Issues and Actions 48
5.4.1 Meetings 48
5.4.2 Program and Policy Issues 48
5.4.3 Recently Issued Significant Enforcement Actions 49
5.4.3.1 Stark II Regulations 49
5.4.3.2 Recent Impact of Stark II Regulations 50
5.4.3.3 Reimbursement 50
6. Business Affairs (Mergers, Acquisitions and Partnerships) 51
6.1 Recent Corporate Partnerships and Mergers 51
6.2 Recent Industry Activity 51
6.3 Product Launches and Developments 52
7. Technology Trends 54
7.1 Hardware (Nuclear Medicine Instrumentation) 54
7.2 Software (PACS) 55
7.2.1 Problems Interfacing PACS and NM 55
7.2.2 SNM and IHE 55
7.2.3 IHE Nuclear Medicine Profile 56
7.2.4 What Next? 57
7.2.5 Optimal Patient Care 57
7.2.6 Four Steps to Standards Adoption 58
7.2.7 Technical Framework: Business with Technology 58
7.2.8 Leading by Example 60
7.2.9 IHE and Electronic Health Record (EHR) 60
7.3 Radiopharmaceuticals and Pharmaceuticals 60
7.3.1 Market Share 61
7.3.2 Contrast Media Market Drivers 61
7.3.3 Contrast Media Market Sector Overview 62
7.3.4 Contrast Media Market Analysis 62
7.3.5 Growth Prospects for Contrast Media 63
7.4 Market Sector Analysis 63
7.5 Leading Companies in General Medical Imaging 65
8. Company Profiles 66
8.1 Hardware (Nuclear Medicine Instrumentation) 66
8.1.1 AccuSync Medical Research 66
8.1.2 Bristol-Myers Squibb (Medical Imaging) 66
8.1.3 Capintec 67
8.1.4 CardiArc 67
8.1.5 Cardinal Health (Cardiology Solutions) 67
8.1.6 Digirad 68
8.1.7 GE Healthcare 68
8.1.8 GVI Medical Devices 69
8.1.9 Hitachi Medical Systems America 70
8.1.10 IS2 Medical Systems 71
8.1.11 Mediso 71
8.1.12 Philips Medical 72
8.1.13 Positron 73
8.1.14 Siemens Medical 73
8.1.15 Spectrum Dynamics 74
8.2 Software (Image Processing and PACS) 75
8.2.1 Heartlab 75
8.2.2 Hermes Medical Solutions 76
8.2.3 INVIA 76
8.2.4 McKesson 77
8.2.5 MedImage 77
8.2.6 MIMvista 77
8.2.7 Numa 78
8.2.8 ProSolv Cardiovascular 78
8.2.9 Scientific Imaging 78
8.2.10 Segami Corporation 78
8.2.11 Syntermed 78
8.2.12 Thinking Systems Corporation 79
8.2.13 UltraSPECT 79
8.2.14 Witt Biomedical Corporation 79
8.3 Radiopharmaceuticals and Pharmaceuticals 79
8.3.1 Astellas Pharma U.S. 79
8.3.2 Bracco Diagnostics 80
8.3.3 Isotope Products Laboratories 80
8.3.4 Izotop: Institute of Isotopes 81
8.3.5 Mallinckrodt 81
8.3.6 Merck 81
8.3.7 NuView Radiopharmaceuticals 83
8.3.8 Pfizer 83
8.3.9 Tyco Healthcare 83
8.4 Ancillary Products 84
8.4.1 CNMTStore.com 84
8.4.2 Data Spectrum Corporation 84
8.4.3 Daxor Corporation 85
8.4.4 Ivy Biomedical Systems 85
8.4.5 MarCal Medical 85
8.5 Service and Support 85
8.5.1 BC Technical 85
8.5.2 Diagnostix Plus 86
8.5.3 MedAxiom 86
8.5.4 MediNuclear Corporation (MNC) 86
8.5.5 MEDX 86
8.5.6 Pinestar Technology 87
8.5.7 Technology Imaging Services 87
8.6 Other Business Opportunities 87
9. Other Elements of Nuclear Medicine Industry 88
9.1 Nuclear Medicine: Guidelines, Certification and Societies 88
9.1.1 American College of Radiology (ACR) 88
9.1.2 American Society of Nuclear Cardiology (ASNC) 88
9.1.3 Associates in Medical Physics (AMP) 88
9.1.4 Certification Board of Nuclear Cardiology (CBNC) 88
9.1.5 ICANL 89
9.1.6 IHE 89
9.1.7 ISO 89
9.1.8 MedPage Today 89
9.1.9 Nuclear Medicine Technology Certification Board (NMTCB) 89
9.1.10 Society of Cardiovascular Computed Tomography (SCCT) 90
9.1.11 Society of Nuclear Medicine (SNM) 90
9.2 Nuclear Medicine: Publications 90
9.2.1 Elsevier 90
9.2.2 HRA Research 91
9.2.3 Lippincott Williams & Wilkins 91
INDEX OF FIGURES
Figure 3.1: U.S. Nuclear Imaging Procedures 24
Figure 3.2: Digirad--Growth of Nuclear Imaging Procedures, 2004-2006 24
Figure 4.1: Nuclear Imaging 30
Figure 4.2: PET Scan 31
Figure 4.3: SPECT Scan 32
Figure 4.4: PET-CT Scan 35
Figure 4.5: SPECT-CT Scan 37
Figure 7.1: IHE Technical Framework 57
Figure 7.2: IHE Framework Organization 59
Figure 7.3: IHE Actors and Transactions 59
INDEX OF TABLES
Table 2.1: U.S. Medical Imaging Market Size, 2001-2010 9
Table 2.2: Global Medical Imaging Market Size, 2001-2010 9
Table 2.3: U.S. Health Expenditures as a Percentage of GDP, 2000-2010 10
Table 2.4: U.S. User Expenditures for Medical Imaging Equipment and Related Products 10
Table 2.5: Millions of Americans Over 65 Years of Age, 2000-2050 11
Table 2.6: Hospital Survey 11
Table 2.7: Percent Change in Volume of Examinations per Imaging Modality, 1993-2004 14
Table 2.8: Worldwide Market Share of Medical Imaging Companies 15
Table 7.1: Market Share of Contrast Media Players 61
Table 7.2: Contrast Media Market Growth, 2003-2010 62
Table 7.3: Worldwide Imaging Procedures, 2001-2010 64
Table 8.1: Astellas Alliances 80

CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: jenniferc@cmsinfo.com

For more information about us, visit CMSinfo.